当前位置:首页 - 行情中心 - 晨光生物(300138) - 财务分析 - 现金流量表

晨光生物

(300138)

  

流通市值:52.14亿  总市值:63.24亿
流通股本:3.98亿   总股本:4.83亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,952,480,341.221,817,655,715.387,591,161,036.985,058,450,186.96
  收到的税费返还107,000,632.1567,535,729.33102,921,119.799,666,812.72
  收到其他与经营活动有关的现金38,985,879.2433,405,513.7184,659,672.63158,577,895.51
  经营活动现金流入小计4,098,466,852.611,918,596,958.417,878,741,829.315,316,694,895.19
  购买商品、接受劳务支付的现金2,007,927,012.731,233,677,978.337,568,768,067.63,296,300,133.06
  支付给职工以及为职工支付的现金129,978,141.664,956,734.38252,264,199.61189,378,670.95
  支付的各项税费59,416,285.8129,982,725.2110,179,820.2890,508,447.67
  支付其他与经营活动有关的现金71,408,773.1359,535,112.53170,344,701.79137,321,034.41
  经营活动现金流出小计2,268,730,213.271,388,152,550.448,101,556,789.283,713,508,286.09
  经营活动产生的现金流量净额1,829,736,639.34530,444,407.97-222,814,959.971,603,186,609.1
二、投资活动产生的现金流量:
  收回投资收到的现金1,755,275,796.41,084,403,155.61,021,788,639.791,155,980,563.47
  取得投资收益收到的现金33,969,630.049,683,526.8238,572,939.8310,788,235.64
  处置固定资产、无形资产和其他长期资产收回的现金净额4,381,729.224,402,32016,655.5394,149.53
  投资活动现金流入小计1,793,627,155.661,098,489,002.421,060,378,235.151,166,862,948.64
  购建固定资产、无形资产和其他长期资产支付的现金55,852,452.9825,054,833.31149,537,086.88149,980,402.64
  投资支付的现金3,060,619,929.272,550,042,486.951,337,369,151.29801,677,762.46
  支付其他与投资活动有关的现金--14,426,983.15-
  投资活动现金流出小计3,116,472,382.252,575,097,320.261,501,333,221.32951,658,165.1
  投资活动产生的现金流量净额-1,322,845,226.59-1,476,608,317.84-440,954,986.17215,204,783.54
三、筹资活动产生的现金流量:
  取得借款收到的现金1,965,690,035.91,505,278,154.265,783,439,209.463,448,038,020.2
  收到其他与筹资活动有关的现金---220,000,000
  筹资活动现金流入小计1,965,690,035.91,505,278,154.265,783,439,209.463,668,038,020.2
  偿还债务支付的现金1,603,829,488.96311,000,0005,087,427,9593,643,082,969
  分配股利、利润或偿付利息支付的现金125,010,139.424,287,014.63174,848,426.65152,004,899.95
  其中:子公司支付给少数股东的股利、利润--793,517.8793,517.8
  支付其他与筹资活动有关的现金1,693,835-417,362,455.29444,515,155.91
  筹资活动现金流出小计1,730,533,463.36335,287,014.635,679,638,840.944,239,603,024.86
  筹资活动产生的现金流量净额235,156,572.541,169,991,139.63103,800,368.52-571,565,004.66
四、汇率变动对现金及现金等价物的影响-2,226,398.82-2,338,013.84-10,493,145.08-6,716,726.56
五、现金及现金等价物净增加额739,821,586.47221,489,215.92-570,462,722.71,240,109,661.42
  加:期初现金及现金等价物余额514,802,240.02514,802,240.021,085,264,962.721,085,264,962.72
  期末现金及现金等价物余额1,254,623,826.49736,291,455.94514,802,240.022,325,374,624.14
补充资料:
  净利润221,253,745.12-77,957,113.49-
  资产减值准备13,183,693.56-95,164,207.13-
  固定资产和投资性房地产折旧84,586,334.61-157,696,415.82-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧84,586,334.61-157,696,415.82-
  无形资产摊销4,817,267.04-8,969,905.84-
  长期待摊费用摊销100,000.02-200,000.04-
  处置固定资产、无形资产和其他长期资产的损失-3,982,574.33--4,887,839.58-
  固定资产报废损失48,622.16-457,881.85-
  公允价值变动损失-2,296,924.13-5,111,280.46-
  财务费用58,758,941.51-114,417,669.76-
  投资损失-27,436,415.66--17,787,444.36-
  递延所得税10,740,485.68--14,036,732.47-
  其中:递延所得税资产减少11,403,111.55--12,171,171.29-
    递延所得税负债增加-662,625.87--1,865,561.18-
  存货的减少1,567,849,044.57--670,569,278.44-
  经营性应收项目的减少49,111,465.11-62,071,449.5-
  经营性应付项目的增加-145,556,542.22--41,673,355.69-
  现金的期末余额1,254,623,826.49-514,802,240.02-
  减:现金的期初余额514,802,240.02-875,264,962.72-
  减:现金等价物的期初余额--210,000,000-
  现金及现金等价物的净增加额739,821,586.47--570,462,722.7-
公告日期2025-08-262025-04-262025-04-082024-10-26
审计意见(境内)标准无保留意见
TOP↑